Peak6 LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Peak6 LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2025 Nov 13, 2025	SELL	$311.12 - $482.13 $186,672 - $289,278	-600 Reduced 46.15%	700 $319,000
Q2 2025 Aug 13, 2025	SELL	$224.32 - $326.09 $2.69 Million - $3.91 Million	-12,000 Reduced 90.23%	1,300 $423,000
Q1 2025 May 14, 2025	SELL	$233.07 - $290.7 $8.02 Million - $10 Million	-34,400 Reduced 72.12%	13,300 $3.59 Million
Q4 2024 Feb 13, 2025	BUY	$232.27 - $300.43 $11.1 Million - $14.3 Million	47,700 New	47,700 $11.2 Million

916

117M

1.25M

1.49M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $55.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 LLC with notifications on news.